The lawyer for an ex-Pfizer employee bringing a whistleblower suit against Pfizer said he isn't phased by the government's decision to refrain from the case.

Novo Nordisk signed an exclusive agreement with Sciele Pharma to market Prandin (repaglinide).

Cephalon said it will pay $425 million to settle a US Justice Department investigation into practices of off-label marketing of products including its pain reliever Actiq.

Merck will pay $4.85 billion to settle the nearly 27,000 Vioxx lawsuits filed against the company by persons or family members claiming the drug injured or caused the death of its users.

A federal judge has dismissed part of the lawsuit brought by Johnson & Johnson against the American Red Cross seeking to restrict the relief organization's use of its iconic logo on first aid, health, safety and emergency preparedness products.

AstraZeneca has been issued a generic challenge to its blockbuster cholesterol drug Crestor (rosuvastatin calcium) by Canada's Cobalt Pharmaceuticals.

Bristol-Myers Squibb (BMS) has entered into a corporate integrity agreement (CIA) with the Office of Inspector General of the Department of Health and Human Services as part of a civil settlement to resolve allegations that the company inflated its drug prices and was involved in kickbacks to doctors.

Hours before the expiration of the Prescription Drug User Fee Act, the Senate approved legislation renewing the program and giving the FDA new powers to police drug safety, thus averting imminent FDA layoffs.

A task force convened by New Jersey Attorney General Anne Milgram was scheduled to meet yesterday to explore the issue of pharma gift-giving to physicians.

New York State Attorney General Andrew Cuomo and New York City Mayor Michael Bloomberg have filed a joint lawsuit against Merck, alleging the drugmaker misrepresented the cardiovascular risks associated with its Vioxx painkiller.